Does the media favor SRTA or NEO?

In the previous week, Strata Critical Medical had 3 more articles in the media than NeoGenomics. MarketBeat recorded 9 mentions for Strata Critical Medical and 6 mentions for NeoGenomics. NeoGenomics' average media sentiment score of 1.34 beat Strata Critical Medical's score of 0.52 indicating that NeoGenomics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Strata Critical Medical 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive NeoGenomics 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SRTA or GRDN?

In the previous week, Strata Critical Medical and Strata Critical Medical both had 9 articles in the media. Guardian Pharmacy Services' average media sentiment score of 0.72 beat Strata Critical Medical's score of 0.52 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Strata Critical Medical 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Guardian Pharmacy Services 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ASTH or SRTA?

In the previous week, Astrana Health had 1 more articles in the media than Strata Critical Medical. MarketBeat recorded 10 mentions for Astrana Health and 9 mentions for Strata Critical Medical. Strata Critical Medical's average media sentiment score of 0.52 beat Astrana Health's score of 0.42 indicating that Strata Critical Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Astrana Health 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Strata Critical Medical 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to SRTA or AGL?

In the previous week, Strata Critical Medical had 5 more articles in the media than Agilon Health. MarketBeat recorded 9 mentions for Strata Critical Medical and 4 mentions for Agilon Health. Strata Critical Medical's average media sentiment score of 0.52 beat Agilon Health's score of 0.14 indicating that Strata Critical Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Strata Critical Medical 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Agilon Health 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor INNV or SRTA?

In the previous week, Strata Critical Medical had 5 more articles in the media than InnovAge. MarketBeat recorded 9 mentions for Strata Critical Medical and 4 mentions for InnovAge. InnovAge's average media sentiment score of 1.78 beat Strata Critical Medical's score of 0.52 indicating that InnovAge is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InnovAge 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Strata Critical Medical 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Strata Critical Medical (SRTA) Competitors

$5.90 -0.07 (-1.17%)

Closing price 04:00 PM Eastern

Extended Trading

$5.84 -0.06 (-0.93%)

As of 07:59 PM Eastern

Compare

SRTA vs. NEO, GRDN, ASTH, AGL, and INNV

Should you buy Strata Critical Medical stock or one of its competitors? Strata Critical Medical's main competitors and comparable companies include NeoGenomics (NEO), Guardian Pharmacy Services (GRDN), Astrana Health (ASTH), Agilon Health (AGL), and InnovAge (INNV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Strata Critical Medical compare to NeoGenomics?

Strata Critical Medical (NASDAQ:SRTA) and NeoGenomics (NASDAQ:NEO) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

Strata Critical Medical has a net margin of 15.71% compared to NeoGenomics' net margin of -6.77%. NeoGenomics' return on equity of -1.99% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
NeoGenomics	-6.77%	-1.99%	-1.21%

Strata Critical Medical presently has a consensus price target of $8.00, indicating a potential upside of 35.59%. NeoGenomics has a consensus price target of $16.71, indicating a potential upside of 4.86%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Strata Critical Medical is more favorable than NeoGenomics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
NeoGenomics	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, Strata Critical Medical had 3 more articles in the media than NeoGenomics. MarketBeat recorded 9 mentions for Strata Critical Medical and 6 mentions for NeoGenomics. NeoGenomics' average media sentiment score of 1.34 beat Strata Critical Medical's score of 0.52 indicating that NeoGenomics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Strata Critical Medical	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
NeoGenomics	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Strata Critical Medical has higher earnings, but lower revenue than NeoGenomics. Strata Critical Medical is trading at a lower price-to-earnings ratio than NeoGenomics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.59	$41.35M	-$0.04	N/A
NeoGenomics	$727.33M	2.82	-$108.03M	-$0.40	N/A

47.4% of Strata Critical Medical shares are held by institutional investors. Comparatively, 98.5% of NeoGenomics shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by insiders. Comparatively, 1.1% of NeoGenomics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Strata Critical Medical has a beta of 2.25, meaning that its share price is 125% more volatile than the broader market. Comparatively, NeoGenomics has a beta of 1.74, meaning that its share price is 74% more volatile than the broader market.

Summary

Strata Critical Medical beats NeoGenomics on 8 of the 15 factors compared between the two stocks.

How does Strata Critical Medical compare to Guardian Pharmacy Services?

Strata Critical Medical (NASDAQ:SRTA) and Guardian Pharmacy Services (NYSE:GRDN) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Strata Critical Medical has a net margin of 15.71% compared to Guardian Pharmacy Services' net margin of 4.50%. Guardian Pharmacy Services' return on equity of 29.97% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
Guardian Pharmacy Services	4.50%	29.97%	16.18%

Strata Critical Medical presently has a consensus target price of $8.00, suggesting a potential upside of 35.59%. Guardian Pharmacy Services has a consensus target price of $43.83, suggesting a potential upside of 14.20%. Given Strata Critical Medical's higher possible upside, equities research analysts clearly believe Strata Critical Medical is more favorable than Guardian Pharmacy Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Guardian Pharmacy Services	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

47.4% of Strata Critical Medical shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by insiders. Comparatively, 33.0% of Guardian Pharmacy Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Strata Critical Medical has a beta of 2.25, indicating that its stock price is 125% more volatile than the broader market. Comparatively, Guardian Pharmacy Services has a beta of 0.1, indicating that its stock price is 90% less volatile than the broader market.

Guardian Pharmacy Services has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.59	$41.35M	-$0.04	N/A
Guardian Pharmacy Services	$1.45B	1.32	$49.22M	$1.03	37.27

In the previous week, Strata Critical Medical and Strata Critical Medical both had 9 articles in the media. Guardian Pharmacy Services' average media sentiment score of 0.72 beat Strata Critical Medical's score of 0.52 indicating that Guardian Pharmacy Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Strata Critical Medical	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardian Pharmacy Services	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Guardian Pharmacy Services beats Strata Critical Medical on 9 of the 15 factors compared between the two stocks.

How does Strata Critical Medical compare to Astrana Health?

Astrana Health (NASDAQ:ASTH) and Strata Critical Medical (NASDAQ:SRTA) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

Astrana Health has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.25, meaning that its stock price is 125% more volatile than the broader market.

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 47.4% of Strata Critical Medical shares are held by institutional investors. 20.3% of Astrana Health shares are held by company insiders. Comparatively, 15.5% of Strata Critical Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Strata Critical Medical has a net margin of 15.71% compared to Astrana Health's net margin of 1.05%. Astrana Health's return on equity of 10.30% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.05%	10.30%	3.67%
Strata Critical Medical	15.71%	-2.97%	-2.54%

Strata Critical Medical has lower revenue, but higher earnings than Astrana Health. Strata Critical Medical is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.71	$22.49M	$0.82	49.77
Strata Critical Medical	$197.14M	2.59	$41.35M	-$0.04	N/A

Astrana Health presently has a consensus target price of $49.43, suggesting a potential upside of 21.12%. Strata Critical Medical has a consensus target price of $8.00, suggesting a potential upside of 35.59%. Given Strata Critical Medical's higher possible upside, analysts plainly believe Strata Critical Medical is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, Astrana Health had 1 more articles in the media than Strata Critical Medical. MarketBeat recorded 10 mentions for Astrana Health and 9 mentions for Strata Critical Medical. Strata Critical Medical's average media sentiment score of 0.52 beat Astrana Health's score of 0.42 indicating that Strata Critical Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Strata Critical Medical	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Astrana Health beats Strata Critical Medical on 9 of the 16 factors compared between the two stocks.

How does Strata Critical Medical compare to Agilon Health?

Strata Critical Medical (NASDAQ:SRTA) and Agilon Health (NYSE:AGL) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

47.4% of Strata Critical Medical shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by insiders. Comparatively, 2.5% of Agilon Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Strata Critical Medical currently has a consensus price target of $8.00, indicating a potential upside of 35.59%. Agilon Health has a consensus price target of $86.18, indicating a potential downside of 10.80%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, analysts plainly believe Strata Critical Medical is more favorable than Agilon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20

Strata Critical Medical has a net margin of 15.71% compared to Agilon Health's net margin of -3.92%. Strata Critical Medical's return on equity of -2.97% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
Agilon Health	-3.92%	-119.38%	-16.85%

Strata Critical Medical has higher earnings, but lower revenue than Agilon Health. Strata Critical Medical is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.59	$41.35M	-$0.04	N/A
Agilon Health	$5.93B	0.27	-$391.35M	-$14.27	N/A

In the previous week, Strata Critical Medical had 5 more articles in the media than Agilon Health. MarketBeat recorded 9 mentions for Strata Critical Medical and 4 mentions for Agilon Health. Strata Critical Medical's average media sentiment score of 0.52 beat Agilon Health's score of 0.14 indicating that Strata Critical Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Strata Critical Medical	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilon Health	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Strata Critical Medical has a beta of 2.25, indicating that its share price is 125% more volatile than the broader market. Comparatively, Agilon Health has a beta of 3.01, indicating that its share price is 201% more volatile than the broader market.

Summary

Strata Critical Medical beats Agilon Health on 13 of the 16 factors compared between the two stocks.

How does Strata Critical Medical compare to InnovAge?

InnovAge (NASDAQ:INNV) and Strata Critical Medical (NASDAQ:SRTA) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, risk and valuation.

In the previous week, Strata Critical Medical had 5 more articles in the media than InnovAge. MarketBeat recorded 9 mentions for Strata Critical Medical and 4 mentions for InnovAge. InnovAge's average media sentiment score of 1.78 beat Strata Critical Medical's score of 0.52 indicating that InnovAge is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InnovAge	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Strata Critical Medical	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

12.3% of InnovAge shares are held by institutional investors. Comparatively, 47.4% of Strata Critical Medical shares are held by institutional investors. 1.0% of InnovAge shares are held by insiders. Comparatively, 15.5% of Strata Critical Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

InnovAge has a beta of 0.39, indicating that its stock price is 61% less volatile than the broader market. Comparatively, Strata Critical Medical has a beta of 2.25, indicating that its stock price is 125% more volatile than the broader market.

InnovAge currently has a consensus target price of $7.00, suggesting a potential downside of 34.02%. Strata Critical Medical has a consensus target price of $8.00, suggesting a potential upside of 35.59%. Given Strata Critical Medical's stronger consensus rating and higher possible upside, analysts clearly believe Strata Critical Medical is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Strata Critical Medical has lower revenue, but higher earnings than InnovAge. Strata Critical Medical is trading at a lower price-to-earnings ratio than InnovAge, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InnovAge	$853.70M	1.69	-$30.31M	-$0.09	N/A
Strata Critical Medical	$197.14M	2.59	$41.35M	-$0.04	N/A

Strata Critical Medical has a net margin of 15.71% compared to InnovAge's net margin of -1.22%. Strata Critical Medical's return on equity of -2.97% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InnovAge	-1.22%	-4.73%	-2.20%
Strata Critical Medical	15.71%	-2.97%	-2.54%

Summary

Strata Critical Medical beats InnovAge on 13 of the 16 factors compared between the two stocks.

Get Strata Critical Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRTA vs. The Competition

Export

Metric	Strata Critical Medical	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$516.56M	$9.88B	$6.98B	$13.04B
Dividend Yield	N/A	2.55%	2.58%	10.72%
P/E Ratio	N/A	35.18	269.86	25.30
Price / Sales	2.59	4.80	601.81	101.06
Price / Cash	N/A	124.00	70.53	50.75
Price / Book	1.83	5.35	13.08	6.33
Net Income	$41.35M	$309.96M	$3.45B	$347.70M
7 Day Performance	1.90%	0.21%	1.12%	1.07%
1 Month Performance	11.74%	0.60%	1.79%	1.03%
1 Year Performance	N/A	20.36%	67.69%	20.77%

Strata Critical Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRTA Strata Critical Medical	2.3724 of 5 stars	$5.90 -1.2%	$8.00 +35.6%	N/A	$516.56M	$197.14M	N/A	130	News Coverage
NEO NeoGenomics	1.9716 of 5 stars	$15.73 -3.4%	$16.71 +6.3%	+162.7%	$2.02B	$727.33M	N/A	2,500
GRDN Guardian Pharmacy Services	3.2772 of 5 stars	$40.48 -0.1%	$42.83 +5.8%	+61.9%	$2.01B	$1.45B	48.77	3,600
ASTH Astrana Health	3.6884 of 5 stars	$35.83 +0.4%	$47.86 +33.6%	+27.5%	$2.00B	$3.53B	58.74	3,000	News Coverage
AGL Agilon Health	0.9006 of 5 stars	$106.55 +12.4%	$66.50 -37.6%	+242.4%	$1.78B	$5.93B	N/A	1,076	Analyst Forecast High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRTA) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Strata Critical Medical (SRTA) Competitors

SRTA vs. NEO, GRDN, ASTH, AGL, and INNV

How does Strata Critical Medical compare to NeoGenomics?

Summary

How does Strata Critical Medical compare to Guardian Pharmacy Services?

Summary

How does Strata Critical Medical compare to Astrana Health?

Summary

How does Strata Critical Medical compare to Agilon Health?

Summary

How does Strata Critical Medical compare to InnovAge?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTA vs. The Competition

Strata Critical Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Strata Critical Medical (SRTA) Competitors

SRTA vs. NEO, GRDN, ASTH, AGL, and INNV

How does Strata Critical Medical compare to NeoGenomics?

Is SRTA or NEO more profitable?

Do analysts recommend SRTA or NEO?

Does the media favor SRTA or NEO?

Which has stronger valuation and earnings, SRTA or NEO?

Do institutionals and insiders have more ownership in SRTA or NEO?

Which has more risk and volatility, SRTA or NEO?

Summary

How does Strata Critical Medical compare to Guardian Pharmacy Services?

Is SRTA or GRDN more profitable?

Do analysts rate SRTA or GRDN?

Do institutionals & insiders hold more shares of SRTA or GRDN?

Which has more risk and volatility, SRTA or GRDN?

Which has better earnings & valuation, SRTA or GRDN?

Does the media prefer SRTA or GRDN?

Summary

How does Strata Critical Medical compare to Astrana Health?

Which has more volatility & risk, ASTH or SRTA?

Do insiders and institutionals believe in ASTH or SRTA?

Is ASTH or SRTA more profitable?

Which has better valuation and earnings, ASTH or SRTA?

Do analysts rate ASTH or SRTA?

Does the media refer more to ASTH or SRTA?

Summary

How does Strata Critical Medical compare to Agilon Health?

Do institutionals and insiders have more ownership in SRTA or AGL?

Do analysts prefer SRTA or AGL?

Is SRTA or AGL more profitable?

Which has better earnings & valuation, SRTA or AGL?

Does the media refer more to SRTA or AGL?

Which has more volatility & risk, SRTA or AGL?

Summary

How does Strata Critical Medical compare to InnovAge?

Does the media favor INNV or SRTA?

Do insiders and institutionals have more ownership in INNV or SRTA?

Which has more volatility and risk, INNV or SRTA?

Do analysts recommend INNV or SRTA?

Which has better earnings and valuation, INNV or SRTA?

Is INNV or SRTA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTA vs. The Competition

Strata Critical Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools